Purpose To evaluate the safety and efficacy of mitomycin-C (MMC) 0.01%(0.1 mg/mL) in
preventing haze formation after wavefront-guided photorefractive keratectomy (PRK) for …

Background To study the effect of prophylactic application of mitomycin-C on haze formation
in photorefractive keratectomy (PRK) for high myopia. Methods Fifty-four eyes of 28 myopic …

Abstract Purpose To compare MMC 0.002% efficacy in preventing haze after PRK in relation
to MMC 0.02%. Patients and methods We conducted a prospective study with patients with …

Purpose: To identify preoperative and intraoperative factors affecting breakthrough corneal
haze incidence after photorefractive keratectomy (PRK) with mitomycin C (MMC). Methods …

Purpose: To evaluate the results of the prophylactic use of mitomycin-C to inhibit haze
formation after excimer laser photorefractive keratectomy (PRK) for medium and high …

PURPOSE: To retrospectively assess risk factors other than high myopia for corneal haze in
patients who had conventional photorefractive keratectomy (PRK) without mitomycin-C …

ABSTRACT PURPOSE: To evaluate the efficacy, safety, and predictability of therapeutic
scraping and application of a diluted 0.02% mitomycin C solution to treat haze and …

Purpose: To evaluate the long-term corneal safety of topical mitomycin C (MMC) used during
photorefractive keratectomy to prevent haze formation in highly myopic eyes. Methods …

PURPOSE: To evaluate the safety and efficacy of 5 seconds of mitomycin-C (MMC)
application during photorefractive keratectomy (PRK) for low myopia. SETTING: Basir Eye …

ABSTRACT PURPOSE: To evaluate the safety and efficacy of phototherapeutic keratectomy
(PTK) with single application of mitomycin C for patients with severe corneal haze following …